Search Results - "Cabo, Erik"

Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group by Alonso‐Álvarez, Sara, Magnano, Laura, Alcoceba, Miguel, Andrade‐Campos, Marcio, Espinosa‐Lara, Natalia, Rodríguez, Guillermo, Mercadal, Santiago, Carro, Itziar, Sancho, Juan M., Moreno, Miriam, Salar, Antonio, García‐Pallarols, Francesc, Arranz, Reyes, Cannata, Jimena, Terol, María José, Teruel, Ana I., Rodríguez, Antonia, Jiménez‐Ubieto, Ana, González de Villambrosia, Sonia, Bello, José L., López, Lourdes, Monsalvo, Silvia, Novelli, Silvana, Cabo, Erik, Infante, María S., Pardal, Emilia, García‐Álvarez, María, Delgado, Julio, González, Marcos, Martín, Alejandro, López‐Guillermo, Armando, Caballero, María D.

“…Summary The diagnostic criteria for follicular lymphoma (FL) transformation vary among the largest series, which commonly exclude histologically‐documented…”
Get full text

Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population by Magnano, Laura, Alonso‐Alvarez, Sara, Alcoceba, Miguel, Rivas‐Delgado, Alfredo, Muntañola, Anna, Nadeu, Ferran, Setoain, Xavier, Rodríguez, Sonia, Andrade‐Campos, Marcio, Espinosa‐Lara, Natalia, Rodríguez, Guillermo, Sancho, Juan Manuel, Moreno, Miriam, Mercadal, Santiago, Carro, Itziar, Salar, Antonio, Garcia‐Pallarols, Francesc, Arranz, Reyes, Cannata, Jimena, Terol, María J., Teruel, Ana I., Jiménez‐Ubieto, Ana, Rodriguez, Antonia, González de Villambrosía, Sonia, Bello, José L., López, Lourdes, Novelli, Silvana, Cabo, Erik, Infante, María E., Pardal, Emilia, Monsalvo, Silvia, González, Marcos, Martín, Alejandro, Caballero, M. Dolores, López‐Guillermo, Armando

“…Summary The use of immunochemotherapy has improved the outcome of follicular lymphoma (FL). Recently, complete response at 30 months (CR30) has been suggested…”
Get full text

Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia by González‐López, Tomás José, Sánchez‐González, Blanca, Jarque, Isidro, Bernat, Silvia, Fernández‐Fuertes, Fernando, Caparrós, Isabel, Soto, Inmaculada, Fernández‐Rodríguez, Angeles, Bolaños, Estefanía, Pérez‐Rus, Gloria, Pascual, Cristina, Hernández‐Rivas, José Angel, López‐Ansoar, Elsa, Gómez‐Nuñez, Marta, Martínez‐Robles, Violeta, Olivera, Pavel, Yera Cobo, Maria, Peñarrubia, María Jesús, Fernández‐Miñano, Carmen, Cabo, Erik, Martínez Badas, María Paz, Perdomo, Germán, García‐Frade, Luis Javier

“…Background Eltrombopag is useful for immune thrombocytopenia (ITP). However, results of clinical trials may not accurately mirror clinical practice reality…”
Get full text

Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice by González-López, Tomás José, Alvarez-Román, María Teresa, Pascual, Cristina, Sánchez-González, Blanca, Fernández-Fuentes, Fernando, Jarque, Isidro, Pérez-Rus, Gloria, Pérez-Crespo, Susana, Bernat, Silvia, Hernández-Rivas, José Angel, Andrade, Marcio M., Cortés, Montserrat, Gómez-Nuñez, Marta, Olivera, Pavel, Martínez-Robles, Violeta, Fernández-Rodríguez, Angeles, Fuertes-Palacio, Miguel Angel, Fernández-Miñano, Carmen, de Cabo, Erik, Fisac, Rosa, Aguilar, Carlos, Bárez, Abelardo, Peñarrubia, María Jesús, García-Frade, Luis Javier, González-Porras, José Ramón

“…Background Eltrombopag is effective and safe in chronic immune thrombocytopenia (ITP). However, clinical trials may not accurately reflect what happens in…”
Get full text

Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia by Gonzalez-Porras, Jose R., Escalante, Fernando, Pardal, Emilia, Sierra, Magdalena, Garcia-Frade, Luis J., Redondo, Santiago, Arefi, Maryam, Aguilar, Carlos, Ortega, Fernando, de Cabo, Erik, Fisac, Rosa M., Sanz, Oscar, Esteban, Carmen, Alberca, Ignacio, Sanchez-Barba, Mercedes, Santos, Maria T., Fernandez, Abel, Gonzalez-Lopez, Tomas J.

“…Aim Few studies specifically focus on elderly splenectomized immune thrombocytopenia (ITP) patients. Older patients with ITP and excellent health are often…”
Get full text

Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience by Rodriguez-Otero, Paula, Sirvent, Maialen, González-Rodríguez, Ana Pilar, Lavilla, Esperanza, de Coca, Alfonso García, Arguiñano, José María, Martí, Josep M., Cabañas, Valentin, Motlló, Cristina, de Cabo, Erik, Encinas, Cristina, Murillo, Ilda, Hernández-Rivas, Jose Ángel, Pérez-Persona, Ernesto, Casado, Felipe, Sampol, Antonia, García, Ricarda, Blanchard, María Jesús, Anguita, Magdalena, Lafuente, Ana Paz, Iñigo, Belén, López, Aurelio, Ribas, Paz, Arnao, Mario, Maldonado, Roberto, Bladé, Joan, Mateos, María Victoria, Lahuerta, Juan José, San Miguel, Jesús F.

“…Treatment of relapsed/refractory multiple myeloma (RRMM) is highly challenging, especially for patients with disease refractory to initial therapy, and in…”
Get full text

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice by González-López, Tomás José, Bermejo-Vega, Nuria, Cardesa-Cabrera, Rocío, Martínez-Robles, Violeta, Aguilar-Monserrate, Gerardo, Pérez-Segura, Gloria, Domingo, Abel, Luis-Navarro, Josefa, Lakhwani, Sunil, Acedo, Natalia, Lozano, María Luisa, Bernat, Silvia, Torres-Tienza, Ana, Ruano, Ana, Jarque, Isidro, Galán, Pilar, Benet, Carmen, Marcellini, Shally, Jimenez-Bárcenas, Reyes, Martínez-Carballeira, Daniel, De Miguel-Llorente, Dunia, Perona-Blázquez, Alvaro, Gonzalez-Gascón, Isabel, Lopez-Ansoar, Elsa, Alonso-Alonso, José María, Bengochea-Casado, María Luisa, Díaz-Gálvez, Francisco Javier, Moretó, Ana, Moreno-Jiménez, Gemma, Hernández-Martin, Roberto, de Cabo, Erik, Dávila-Valls, Julio, Cuesta, Amalia, Pastoriza, Carmen, Hermida-Fernández, Gerardo Julio, García, Covadonga, Pozas-Mañas, Miguel Angel, Aguilar, Carlos, Fernandez-Jimenez, Dolores, Navas-Elorza, Begoña, López-Santamaría Castro, Carolina, Lorenzo, Alvaro, Ortín, Xavier, García, Marta, Piernas, Sonia, Díaz-Santa, Johana, Soto, Inmaculada, Provan, Drew, García-Donas Gabaldón, Gloria

“…•Similar to clinical trial results, fostamatinib has demonstrated a high efficacy rate for ITP in daily clinical practice conditions.•Fostamatinib is a…”
Get full text

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia by González‐López, Tomás José, Pascual, Cristina, Álvarez‐Román, María Teresa, Fernández‐Fuertes, Fernando, Sánchez‐González, Blanca, Caparrós, Isabel, Jarque, Isidro, Mingot‐Castellano, María Eva, Hernández‐Rivas, José Angel, Martín‐Salces, Mónica, Solán, Laura, Beneit, Paola, Jiménez, Reyes, Bernat, Silvia, Andrade, Marcio M., Cortés, Montserrat, Cortti, Maria José, Pérez‐Crespo, Susana, Gómez‐Núñez, Marta, Olivera, Pavel E., Pérez‐Rus, Gloria, Martínez‐Robles, Violeta, Alonso, Rafael, Fernández‐Rodríguez, Angeles, Arratibel, María Carmen, Perera, María, Fernández‐Miñano, Carmen, Fuertes‐Palacio, Miguel Angel, Vázquez‐Paganini, Juan Andrés, Gutierrez‐Jomarrón, Isabel, Valcarce, Inés, de Cabo, Erik, Sainz, Adriana, Fisac, Rosa, Aguilar, Carlos, Paz Martínez‐Badas, María, Peñarrubia, María Jesús, Calbacho, María, de Cos, Carmen, González‐Silva, Manuel, Coria, Erika, Alonso, Arancha, Casaus, Alberto, Luaña, Armando, Galán, Pilar, Fernández‐Canal, Cristina, Garcia‐Frade, Javier, González‐Porras, José Ramón

“…Eltrombopag is effective and safe in immune thrombocytopenia (ITP). Some patients may sustain their platelet response when treatment is withdrawn but the…”
Get full text

Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice by González-López, Tomás José, Fernández-Fuertes, Fernando, Hernández-Rivas, José Angel, Sánchez-González, Blanca, Martínez-Robles, Violeta, Alvarez-Román, María Teresa, Pérez-Rus, Gloria, Pascual, Cristina, Bernat, Silvia, Arrieta-Cerdán, Esther, Aguilar, Carlos, Bárez, Abelardo, Peñarrubia, María Jesús, Olivera, Pavel, Fernández-Rodríguez, Angeles, de Cabo, Erik, García-Frade, Luis Javier, González-Porras, José Ramón

“…Eltrombopag is safe and effective in primary chronic ITP. However, lack of clinical trials avoids a clear demonstration of its utility in newly diagnosed and…”
Get full text

Effect of Pregnancy on the Clinical Course of ITP Pregnant Women and Their Newborns. Resuts of a Spanish Case Series of 297 Primary ITP Pregnancies by González-López, Tomás José, Olivera, Pavel, Jarque, Isidro, Bastida, Jose Maria, Bernat, Silvia, Sanchez-Gonzalez, Blanca, Bolaños, Estefanía, Perez-Rus, Gloria, Huerta, Ana R., Fernandez-Fuertes, Fernando, Martinez-Robles, Violeta, Martínez-Badas, Maria Paz, Pérez-Montes, Rocio, Penarrubia Ponce, Maria Jesus, Conesa, Venancio, Bermejo, Nuria, Caballero, Gonzalo, Alvarez Roman, Maria Teresa, Fernandez-Miñano, Carmen, Guerrero, Lucia, Marcellini, Shally, Sierra Pacho, Magdalena, Pardal, Emilia, Pastoriza, Carmen, Lopez Ansoar, Maria Elsa, de Cabo, Erik, Hermida, Gerardo, Sanz, Miguel A.

“…Introduction: Given that there is no large case-series, effect of pregnancy on the course of pre-existing primary immune thrombocytopenia (ITP) patients is…”
Get full text

Peripheral Blood Analysis By Flow Cytometry for the Diagnosis of Type I Chronic Myelomonocytic Leukemia by Mya, Hae Tha, Diez Campelo, Maria, Valle Herrero, Sandra, Díaz-Alvarez, Agustin, Bustos, Domingo, Vaquero, Luis M, Pérez, José J, González, Verónica, Bastida, Jose M, Garcia-Coca, Alfonso, de Cabo, Erik, Gonzalez, Tomas, Puig, Noemi, Martin-Sancho, Alejandro, Fernðndez, Patricia, Davila, Julio, Africa Martín López, Ana, González, Marcos, Del Cañizo, Consuelo, Vidriales, Maria Belen

“…Chronic myelomonocytic leukemia (CMML) is a clonal disorder with a diagnostic challenge encountered frequently in routine hematology consultations, especially…”
Get full text

Incidence, Risk Factors and Prognosis of Transformation in Follicular Lymphoma: a Multicentre Retrospective Analysis of 1763 Patients from the Geltamo Spanish Lymphoma Cooperative Group by Alonso, Sara, Alcoceba, Miguel, Magnano, Laura, Andrade, Marcio, García-Álvarez, María, Mercadal, Santiago, Rodríguez, Guillermo, Garcia, Olga, Sancho, Juan-Manuel, Salar, Antonio, Pasarolls, Francesc, Terol, Maria Jose, Grande, Carlos, González de Villambrosia, Sonia, Cordoba, Raul, Novelli, Silvana, López, Lourdes, Montalbán, Carlos, de Cabo, Erik, Infante, Maria Stefania, Pardal, Emilia, Lopez-Jimenez, Javier, Antelo, Beatriz, Arranz, Reyes, González, Marcos, Martín, Alejandro, López-Guillermo‡, Armando, Caballero‡, Maria Dolores

“…INTRODUCTION Follicular lymphoma (FL) may, over time, transform into an aggressive lymphoma, usually diffuse large B-cell lymphoma (DLBCL). Transformed…”
Get full text

Efficacy and Safety of Eltrombopag in Persistent and Newly Diagnosed ITP by González-López, Tomás José, Sánchez-González, Blanca, Pascual, Cristina, Alvarez-Roman, María Teresa, Pérez-Rus, Gloria, Fernández-Fuentes, Fernando, Bernat, Silvia, Hernández-Rivas, José Angel, Cortés, Montserrat, Andrade, Marcio, Olivera, Pavel, Jarque, Isidro, Pérez-Crespo, Susana, Gómez-Nuñez, Marta, Fernández-Rodríguez, Angeles, Martínez-Robles, Violeta, Fernández-Miñano, Carmen, Fuertes-Palacio, Miguel Angel, Bárez, Abelardo, Fisac, Rosa, Aguilar, Carlos, Peñarrubia, María Jesús, de Cabo, Erik, Mingot, Eva, Ranedo-Zaldo, Raquel, Arrieta-Cerdán, Esther, Sanz, Miguel A., García-Frade, Javier, González-Porras, José Ramón

“…Background: Eltrombopag is a thrombopoietin receptor agonist approved for primary chronic ITP patients. Due to the non-existence of clinical trials using…”
Get full text

Sustained Response After Short-Medium-Term Treatment With Eltrombopag In Patients With ITP by González-López, Tomás José, González-Porras, José Ramón, Arefi, Maryam, De Cabo, Erik, Gonzalez, Blanca Sanchez, Alonso, Arancha, Martin, Mónica, Jimenez, Reyes, Calbacho, Maria, Bárez, Abelardo, San Miguel, Jesus F

“…Eltrombopag is an oral, non-peptide thrombopoietic receptor-agonist (TPO-RA). In chronic immune thrombocytopenic purpura (ITP) randomized–controlled trials…”
Get full text

Sustained response after discontinuation of short-and medium-term treatment with eltrombopag in patients with immune thrombocytopenia by González-López, Tomás José, Sánchez-González, Blanca, Pascual, Cristina, Arefi, Maryam, de Cabo, Erik, Alonso, Arancha, Martín-Salces, Mónica, Jiménez-Bárcenas, Reyes, Calbacho, María, Galan, Pilar, Barez, Abelardo, González-Porras, José Ramón

“…Abstract Eltrombopag is effective and safe in chronic immune thrombocytopenia (ITP) patients not responding to previous therapy. However, when eltrombopag is…”
Get full text

Successful Discontinuation of Eltrombopag after Complete Remission in Patients with Primary Immune Thrombocytopenia by González-López, Tomás José, Pascual, Cristina, Álvarez-Román, María Teresa, Fernández-Fuertes, Fernando, Sánchez-González, Blanca, Caparrós, Isabel, Jarque, Isidro, Mingot, María Eva, Hernández-Rivas, José Ángel, Martín-Salces, Mónica, Solán, Laura, Beneit, Paola, Jiménez, Reyes, Bernat, Silvia, Andrade, Marcio M, Cortés, Montserrat, Cortti, Maria José, Pérez-Crespo, Susana, Gómez-Núñez, Marta, Olivera, Pavel E., Pérez-Rus, Gloria, Martínez-Robles, Violeta, Alonso, Rafael, Fernández-Rodríguez, Angeles, Arratibel, María Carmen, Perera, María, Fernández-Miñano, Carmen, Fuertes-Palacio, Miguel Angel, Vázquez-Paganini, Juan Andrés, Gutierrez-Jomarrón, Isabel, Valcarce, Inés, de Cabo, Erik, Sainz, Adriana, Fisac, Rosa, Aguilar, Carlos, Martínez-Badas, María Paz, Peñarrubia, María Jesús, Garcia-Frade, Javier, Calbacho, María, de Cos, Carmen, González-Silva, Manuel, Coria, Erika, Alonso, Arancha, Casaus, Alberto, Luaña, Armando, Galán, Pilar, Fernández-Canal, Cristina, González-Porras, José Ramón

“…Background: Eltrombopag is effective and safe for treating chronic immune thrombocytopenia (ITP) patients who have not responded to previous therapy…”
Get full text

Early Identification of Very High Risk Patients with Diffuse Large B Cell Lymphoma (DLBCL) By PET-CT by Cabero Martínez, Almudena, Diaz Gonzalez, Luis Gonzaga, Montes, Carlos, Cortés-Rodríguez, María, Gutierrez, Norma C., Baile Gonzalez, Monica, García Bacelar, Ana, Lopez Parra, Miriam, Cañadas, Jose Cristobal, Villanueva, Juan Gabriel, Diaz Galvez, Francisco Javier, Peñarrubia-Ponce, María, Fernandez Ferrero, Silvia Maria, Queizan Hernandez, Jose Antonio, Cabezudo, Miguel, De Cabo López, Erik, Villaescusa, Teresa, Tamayo, Pilar, Garcia-Sanz, Ramon, Martin García-Sancho, Alejandro

“…TITLE Early identification of very high risk patients with Diffuse Large B Cell Lymphoma (DLBCL) by PET-CT. INTRODUCTION Early identification of high risk…”
Get full text

Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group by Palanques-Pastor, Tomás, Megías-Vericat, Juan Eduardo, Martínez, Pilar, López Lorenzo, José Luis, Cornago Navascués, Javier, Rodriguez Macias, Gabriela, Cano, Isabel, Arnan Sangerman, Montserrat, Vidriales Vicente, María Belén, Algarra Algarra, Jesús Lorenzo, Foncillas, María Ángeles, Herrera, Pilar, Botella Prieto, Carmen, Vives, Susana, Figuera Álvarez, Ángela, Cuevas Palomares, Laida, Sobas, Marta, Contento Gonzalo, Alejandro, Cuello García, Rebeca, Amutio Diez, María Elena, De Miguel Llorente, Dunia, Navas Elorza, Begoña, Bergua Burgues, Juan Miguel, Bernal Del Castillo, Teresa, Mateos Rodríguez, María Carmen, de Cabo López, Erik, Franco Villegas, Ana Carolina, García Boyero, Raimundo, Escolano Escobar, Cristian, Seri Merino, Cristina, Cervero, Carlos, Roldán Pérez, Alicia, Hermosín Ramos, Lourdes, Cervera Calvo, Marta, Olave, María Telesa, Villafuerte Gutiérrez, Paola, de Laiglesiai, Almudena, Serrano, Josefina, Najera Irazu, María Josefa, Piñana, José Luis, Sanz, Miguel Ángel, Martínez-López, Joaquín, Montesinos, Pau

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces higher morbidity and mortality in hematological malignancies, but evidence in…”
Get full text

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens by Castaño-Bonilla, Tamara, Alonso-Dominguez, Juan M., Barragán, Eva, Rodríguez-Veiga, Rebeca, Sargas, Claudia, Gil, Cristina, Chillón, Carmen, Vidriales, María B., García, Raimundo, Martínez-López, Joaquín, Ayala, Rosa, Larrayoz, María J., Anguita, Eduardo, Cuello, Rebeca, Cantalapiedra, Alberto, Carrillo, Estrella, Soria-Saldise, Elena, Labrador, Jorge, Recio, Isabel, Algarra, Lorenzo, Rodríguez-Medina, Carlos, Bilbao-Syeiro, Cristina, López-López, Juan A., Serrano, Josefina, De Cabo, Erik, Sayas, María J., Olave, María T., Sánchez-García, Joaquín, Mateos, Mamen, Blas, Carlos, López-Lorenzo, Jose L., Lainez-Gonzalez, Daniel, Serrano, Juana, Martínez-Cuadrón, David, Sanz, Miguel A., Montesinos, Pau

“…FLT3- ITD mutations are detected in approximately 25% of newly diagnosed adult acute myeloid leukemia (AML) patients and confer an adverse prognosis. The FLT3…”
Get full text

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry by Martínez, Pilar, Palanques Pastor, Tomás, Lopez Lorenzo, Jose Luiz, Cornago Navascués, Javier, Rodriguez-Macías, Gabriela, Cano, Isabel, Arnan Sangerman, Montserrat, Vidriales, María-Belén, Algarra, Jesús Lorenzo, Foncillas, Maria Angeles, Herrera Puente, Pilar, Botella, Carmen, Vives, Susana, Figuera Alvarez, Angela, Cuevas Palomares, Laida, Sobas, Marta, Contento-Gonzalo, Alejandro, Cuello, Rebeca, Amutio Diez, María Elena, De Miguel, Maria Dunia, Navas, Begoña, Bergua Burgues, Juan Miguel, Bernal del Castillo, Teresa, Mateos Rodríguez, María Carmen, de Cabo López, Erik, Franco Villegas, Ana Carolina, García-Boyero, Raimundo, Escolano Escobar, Cristian, Seri, Cristina, Cervero, Carlos, Roldán Pérez, Alicia, Hermosin, Maria Lourdes, Cervera, Marta, Olave, María Teresa, Villafuerte Gutierrez, Paola Sandra, De Laiglesia, Almudena, Serrano, Josefina, Najera Irazu, María Josefa, Piñana Sanchez, Jose Luis, Sanz, Miguel Ángel, Martinez-Lopez, Joaquin, Montesinos, Pau

“…SARS-CoV-2 infection can impact survival of patients with acute myeloid leukemia (AML). International experts recommend considering delaying or stopping AML…”
Get full text